Epothilone B inhibits neointimal formation after rat carotid injury through the regulation of cell cycle-related proteins

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 648-655

  Lim, Yong ^a   Kim, Tack Joong ^a   Jin, Yong Ri ^a   Kim, Dong Woon ^b   Kwon, Jin Sook ^b   Son, Ju Hee ^b   Jung, Jae Chul ^c   Avery, Mitchell A ^c   Dong, Ju Son ^a   Jin, Tae Hong ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; EPOTHILONE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C GAMMA1; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN P27; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY INJURY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; IN VITRO STUDY; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EPOTHILONES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RETINOBLASTOMA PROTEIN; TUNICA INTIMA;

EID: 34247258485     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.117622     Document Type: Article

References (37)

1. Altmann KH, Wartmann M, and O'Reilly T (2000) Epothilones and related structures - a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim Biophys Acta 1470:M79-M91.
2. Blagosklonny MV, Demidenko ZN, Giovino M, Szynal C, Donskoy E, Herrmann RA, Barry JJ, and Whalen AM (2006) Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent post-mitotic arrest: comparison with cancer cells. Cell Cycle 5:1574-1579.
3. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, and Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55:2325-2333.
4. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, and Leiden JM (1995) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science (Wash DC) 267:518-522.
5. Chen D, Krasinki K, Chen D, Sylvester A, Nisen PD, and Andres V (1997) Down-regulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in VSMC by p27, an inhibitor of neointima formation in the rat carotid artery. J Clin Investig 99:2334-2341.
6. Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023-32026.
7. Clowes AW, Reidy MA, and Clowes MM (1983) Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab Investig 49:327-333.
8. Cui Y, Gutstein WH, Jabr S, Hsieh TC, and Wu JM (1998) Control of human vascular smooth muscle cell proliferation by sera derived from "experimentally stressed" individuals. Oncol Rep 5:1471-1474.
9. Gordon D, Reidy MA, Benditt EP, and Schwartz SM (1990) Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 87:4600-4604.
10. Gutstein WH, Teresi JA, Wu JM, Ramirez M, Salimian F, Cui Y, Paul I, and Jabr S (1999) Increased serum mitogenic activity for arterial smooth muscle cells associated with relaxation and low educational level in human subjects with high but not low hostility traits: implications for atherogenesis. J Psychosom Res 46:51-61.
11. Harper JW, Adami GR, Wei N, Keyomarsi K, and Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
12. Heldin CH, Ostman A, and Ronnstrand L (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378:F79-F113.
13. Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware M Jr, Nater C, Hruban RH, Rezai B, Abella BS, et al. (2001) Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103:2289-2295.
14. Jung JC, Kache R, Vines KK, Zheng YS, Bijoy P, Valluri M, and Avery MA (2004) Total syntheses of epothilones B and D. J Org Chem 69:9269-9284.
15. Kim DW, Kwon JK, Kim YG, Kim MS, Lee GS, Youn TJ, and Cho MC (2004) Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in rat carotid artery injury model. Circulation 109:1558-1563.
16. Kim TJ, Zhang YH, Kim YS, Lee CK, Lee MK, Hong JT, and Yun YP (2002) Effect of apigenin on the serum- and platelet derived growth factor-BB-induced proliferation of rat aortic VSMCs. Planta Med 68:605-609.
17. Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, and McMahon G (1998) Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. J Pharmacol Exp Ther 285:844-852.
18. Morgan DO (1995) Principles of CDK regulation. Nature (Lond) 374:131-134.
19. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Leyen H, Zhang L, Kaneda Y, Ogihara Y, and Dzau VJ (1994) Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Investig 93:1458-1464.
20. Muhlradt PF and Sasse F (1997) Epothilone B stabilizes microtubule of macrophages like taxol without showing taxol-like endotoxin activity. Cancer Res 57:3344-3346.
21. Mulvany MJ (1990) Structure and function of small arteries in hypertension. J Hypertens 8:225-232.
22. Myllärniemi M, Frösen J, Calderón Ramirez LG, Buchdunger E, Lemström K, and Häyry P (1999) Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo. Cardiovasc Drugs Ther 13:159-168.
23. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, et al. (2003) A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348:1537-1545.
24. Peter M and Herskowitz I (1994) Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
25. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
26. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond) 362:801-809.
27. Sachinidis A, Locher R, Vetter W, Tatje D, and Hoppe J (1990) Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem 265:10238-10243.
28. Serrano M, Hannon GH, and Beach DA (1993) New regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond) 366:704-707.
29. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555.
30. Signore PE, Machan LS, Jackson JK, Wilson JE, and Mcmanus BM (2001) Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in Balloon-injured rat carotid arteries. J Vasc Interv Radiol 12:79-88.
31. Sollott SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG, Rowinsky EK, et al. (1995) Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Investig 95:1869-1876.
32. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, and Hamm B (2006) Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240:411-418.
33. Sriram V and Patterson C (2001) Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation 103:2414-2419.
34. Uchida K, Sasahara M, Morigami N, Hazama F, and Kinoshita M (1996) Expression of platelet derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 124:9-23.
35. Waltenberger J (1997) Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation 96:4083-4094.
36. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330.
37. Wu CH, Pan JS, Chang WC, Hung JS, and Mao SJ (2005) The molecular mechanism of actinomycin D in preventing neointimal formation in rat carotid arteries after balloon injury. J Biomed Sci 12:503-512.